vs
Side-by-side financial comparison of Driven Brands Holdings Inc. (DRVN) and Bio-Techne (TECH). Click either name above to swap in a different company.
Driven Brands Holdings Inc. is the larger business by last-quarter revenue ($535.7M vs $311.4M, roughly 1.7× Bio-Techne). Bio-Techne runs the higher net margin — 16.4% vs 11.4%, a 5.0% gap on every dollar of revenue. On growth, Driven Brands Holdings Inc. posted the faster year-over-year revenue change (6.6% vs -1.5%). Over the past eight quarters, Bio-Techne's revenue compounded faster (1.3% CAGR vs -4.0%).
Standard Brands was a packaged foods company, formed in 1929 by J. P. Morgan & Co. with the merger of:Fleischmann Company Royal Baking Powder Company E. W. Gillett Company of Canada (1929) - Toronto-based baking goods company founded by P. W. Gillett in 1852 Widlar Food Products Company Chase & Sanborn Coffee Company
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
DRVN vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $535.7M | $311.4M |
| Net Profit | $60.9M | $51.0M |
| Gross Margin | — | 66.9% |
| Operating Margin | 11.6% | 24.2% |
| Net Margin | 11.4% | 16.4% |
| Revenue YoY | 6.6% | -1.5% |
| Net Profit YoY | 507.2% | 126.0% |
| EPS (diluted) | $0.37 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $311.4M | ||
| Q4 25 | — | $295.9M | ||
| Q3 25 | $535.7M | — | ||
| Q2 25 | $551.0M | $317.0M | ||
| Q1 25 | $516.2M | $316.2M | ||
| Q4 24 | $836.5M | $297.0M | ||
| Q3 24 | $502.3M | $289.5M | ||
| Q2 24 | $518.8M | $306.1M |
| Q1 26 | — | $51.0M | ||
| Q4 25 | — | $38.0M | ||
| Q3 25 | $60.9M | — | ||
| Q2 25 | $47.6M | $-17.7M | ||
| Q1 25 | $5.5M | $22.6M | ||
| Q4 24 | $-312.0M | $34.9M | ||
| Q3 24 | $-14.9M | $33.6M | ||
| Q2 24 | $30.2M | $40.6M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | — | 18.4% | ||
| Q3 25 | 11.6% | — | ||
| Q2 25 | 6.9% | -7.5% | ||
| Q1 25 | 11.9% | 12.2% | ||
| Q4 24 | -41.6% | 16.0% | ||
| Q3 24 | 9.9% | 13.8% | ||
| Q2 24 | 17.4% | 15.0% |
| Q1 26 | — | 16.4% | ||
| Q4 25 | — | 12.8% | ||
| Q3 25 | 11.4% | — | ||
| Q2 25 | 8.6% | -5.6% | ||
| Q1 25 | 1.1% | 7.1% | ||
| Q4 24 | -37.3% | 11.7% | ||
| Q3 24 | -3.0% | 11.6% | ||
| Q2 24 | 5.8% | 13.3% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.37 | — | ||
| Q2 25 | $0.29 | $-0.11 | ||
| Q1 25 | $0.04 | $0.14 | ||
| Q4 24 | $-1.93 | $0.22 | ||
| Q3 24 | $-0.09 | $0.21 | ||
| Q2 24 | $0.18 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $162.0M | $209.8M |
| Total DebtLower is stronger | $1.9B | — |
| Stockholders' EquityBook value | $793.5M | $2.1B |
| Total Assets | $4.2B | $2.6B |
| Debt / EquityLower = less leverage | 2.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $209.8M | ||
| Q4 25 | — | $172.9M | ||
| Q3 25 | $162.0M | — | ||
| Q2 25 | $166.1M | $162.2M | ||
| Q1 25 | $152.0M | $140.7M | ||
| Q4 24 | $149.6M | $177.5M | ||
| Q3 24 | $204.2M | $187.5M | ||
| Q2 24 | $148.8M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $260.0M | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $2.1B | $346.0M | ||
| Q1 25 | $2.6B | $330.0M | ||
| Q4 24 | $2.7B | $300.0M | ||
| Q3 24 | $2.7B | $300.0M | ||
| Q2 24 | $2.9B | $319.0M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | $793.5M | — | ||
| Q2 25 | $743.4M | $1.9B | ||
| Q1 25 | $643.2M | $2.0B | ||
| Q4 24 | $607.3M | $2.1B | ||
| Q3 24 | $962.8M | $2.1B | ||
| Q2 24 | $942.8M | $2.1B |
| Q1 26 | — | $2.6B | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | $4.2B | — | ||
| Q2 25 | $4.3B | $2.6B | ||
| Q1 25 | $5.3B | $2.6B | ||
| Q4 24 | $5.3B | $2.7B | ||
| Q3 24 | $5.8B | $2.7B | ||
| Q2 24 | $5.8B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | 2.44× | — | ||
| Q2 25 | 2.82× | 0.18× | ||
| Q1 25 | 4.07× | 0.16× | ||
| Q4 24 | 4.37× | 0.14× | ||
| Q3 24 | 2.84× | 0.14× | ||
| Q2 24 | 3.03× | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $79.2M | — |
| Free Cash FlowOCF − Capex | $39.5M | — |
| FCF MarginFCF / Revenue | 7.4% | — |
| Capex IntensityCapex / Revenue | 7.4% | — |
| Cash ConversionOCF / Net Profit | 1.30× | — |
| TTM Free Cash FlowTrailing 4 quarters | $31.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $79.2M | — | ||
| Q2 25 | $80.4M | $98.2M | ||
| Q1 25 | $75.1M | $41.1M | ||
| Q4 24 | $32.9M | $84.3M | ||
| Q3 24 | $101.3M | $63.9M | ||
| Q2 24 | $46.9M | $75.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $39.5M | — | ||
| Q2 25 | $9.0M | $93.3M | ||
| Q1 25 | $18.9M | $31.0M | ||
| Q4 24 | $-36.3M | $77.5M | ||
| Q3 24 | $37.9M | $54.7M | ||
| Q2 24 | $-19.5M | $57.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 7.4% | — | ||
| Q2 25 | 1.6% | 29.4% | ||
| Q1 25 | 3.7% | 9.8% | ||
| Q4 24 | -4.3% | 26.1% | ||
| Q3 24 | 7.5% | 18.9% | ||
| Q2 24 | -3.8% | 18.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 7.4% | — | ||
| Q2 25 | 13.0% | 1.5% | ||
| Q1 25 | 10.9% | 3.2% | ||
| Q4 24 | 8.3% | 2.3% | ||
| Q3 24 | 12.6% | 3.2% | ||
| Q2 24 | 12.8% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 13.65× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 1.56× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DRVN
| Company Operated Store Sales | $331.3M | 62% |
| Supply And Other | $74.3M | 14% |
| Car Wash Segment | $54.0M | 10% |
| Independently Operated Store Sales | $51.4M | 10% |
| Advertising | $27.9M | 5% |
| Employee Services Leasing Agreement | $2.0M | 0% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
